Latest investigations into retatritide peptide reveal notable potential for treating weight and type 2 diabetes mellitus. The compound, a dual stimulator of glucagon-like peptide-1 and GIP, seems to provide improved weight loss and glycemic regulation in contrast to existing treatments. Ongoing p